Head and Neck Mucosal Melanoma: Where Are We Now?

Curtis Hanba; Ehab Hanna

doi:10.1007/s11912-024-01513-w

Head and Neck Mucosal Melanoma: Where Are We Now?

Curtis Hanba
, Ehab Hanna

Research output: Contribution to journal › Review article › peer-review

2 Scopus citations

Abstract

Purpose of Review: To highlight recent and relevant treatment considerations while managing mucosal melanoma. Recent Findings: Evidence is building to support the use of targeted therapy and immunotherapy while managing mucosal melanoma. Summary: Surgical resection with postoperative radiotherapy plays a major role in managing resectable disease. Recent studies evaluate the addition of targeted, and immunotherapies with an attempt to determine the most efficacious sequence of treatment.

Original language	English (US)
Pages (from-to)	421-425
Number of pages	5
Journal	Current oncology reports
Volume	26
Issue number	4
DOIs	https://doi.org/10.1007/s11912-024-01513-w
State	Published - Apr 2024
Externally published	Yes

Bibliographical note

Publisher Copyright:
© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024.

Keywords

Mucosal melanoma
Sinonasal melanoma

PubMed: MeSH publication types

Journal Article
Review

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1007/s11912-024-01513-w

Find It

Find It at U of M Libraries

Cite this

@article{249da2ed1f044f0eaf96783e36f2c130,

title = "Head and Neck Mucosal Melanoma: Where Are We Now?",

abstract = "Purpose of Review: To highlight recent and relevant treatment considerations while managing mucosal melanoma. Recent Findings: Evidence is building to support the use of targeted therapy and immunotherapy while managing mucosal melanoma. Summary: Surgical resection with postoperative radiotherapy plays a major role in managing resectable disease. Recent studies evaluate the addition of targeted, and immunotherapies with an attempt to determine the most efficacious sequence of treatment.",

keywords = "Mucosal melanoma, Sinonasal melanoma",

author = "Curtis Hanba and Ehab Hanna",

note = "Publisher Copyright: {\textcopyright} The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024.",

year = "2024",

month = apr,

doi = "10.1007/s11912-024-01513-w",

language = "English (US)",

volume = "26",

pages = "421--425",

journal = "Current oncology reports",

issn = "1523-3790",

publisher = "Springer",

number = "4",

}

TY - JOUR

T1 - Head and Neck Mucosal Melanoma

T2 - Where Are We Now?

AU - Hanba, Curtis

AU - Hanna, Ehab

N1 - Publisher Copyright: © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024.

PY - 2024/4

Y1 - 2024/4

N2 - Purpose of Review: To highlight recent and relevant treatment considerations while managing mucosal melanoma. Recent Findings: Evidence is building to support the use of targeted therapy and immunotherapy while managing mucosal melanoma. Summary: Surgical resection with postoperative radiotherapy plays a major role in managing resectable disease. Recent studies evaluate the addition of targeted, and immunotherapies with an attempt to determine the most efficacious sequence of treatment.

AB - Purpose of Review: To highlight recent and relevant treatment considerations while managing mucosal melanoma. Recent Findings: Evidence is building to support the use of targeted therapy and immunotherapy while managing mucosal melanoma. Summary: Surgical resection with postoperative radiotherapy plays a major role in managing resectable disease. Recent studies evaluate the addition of targeted, and immunotherapies with an attempt to determine the most efficacious sequence of treatment.

KW - Mucosal melanoma

KW - Sinonasal melanoma

UR - https://www.scopus.com/pages/publications/85188252753

UR - https://www.scopus.com/pages/publications/85188252753#tab=citedBy

U2 - 10.1007/s11912-024-01513-w

DO - 10.1007/s11912-024-01513-w

M3 - Review article

C2 - 38512416

AN - SCOPUS:85188252753

SN - 1523-3790

VL - 26

SP - 421

EP - 425

JO - Current oncology reports

JF - Current oncology reports

IS - 4

ER -

Head and Neck Mucosal Melanoma: Where Are We Now?

Abstract

Bibliographical note

Keywords

PubMed: MeSH publication types

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this